Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 101

Results For "pharmaceuticals"

1747 News Found

Kivo launches unified DMS platform ‘Kivo GO’
News | September 27, 2023

Kivo launches unified DMS platform ‘Kivo GO’

Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams


India to launch National Policy on Research and Development and Innovation in Pharma-MedTech
Policy | September 26, 2023

India to launch National Policy on Research and Development and Innovation in Pharma-MedTech

Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)


Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs. 5,652 Cr
News | September 22, 2023

Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs. 5,652 Cr

Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction


USFDA conducts inspection at InvaGen manufacturing facility in Central Islip, NY, USA
Drug Approval | September 21, 2023

USFDA conducts inspection at InvaGen manufacturing facility in Central Islip, NY, USA

InvaGen has received 5 inspectional observations in Form 483


Cenexi appoints Jim McPherson as CEO
People | September 20, 2023

Cenexi appoints Jim McPherson as CEO

Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK


Biocon names Peter Bains as Group CEO
People | September 19, 2023

Biocon names Peter Bains as Group CEO

Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect


Takeda reiterates the need of equitable access to healthcare for universal impact
News | September 18, 2023

Takeda reiterates the need of equitable access to healthcare for universal impact

The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services


Indian pharma industry to witness 8-10% revenue growth in fiscal 2024: CRISIL
News | September 12, 2023

Indian pharma industry to witness 8-10% revenue growth in fiscal 2024: CRISIL

Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable


JB Pharma publishes sustainability report for FY 2022-23
Sustainability | September 12, 2023

JB Pharma publishes sustainability report for FY 2022-23

JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions


Takeda emphasizes DEI to bring equal opportunities for all at the G20 Summit
News | September 08, 2023

Takeda emphasizes DEI to bring equal opportunities for all at the G20 Summit

The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit